Ausgabe 6/2020
Inhalt (14 Artikel)
Biomarkers for infarct diagnosis and rapid rule-out/rule-in of acute myocardial infarction
Evangelos Giannitsis, Vinayak Gopi
Klinische Bedeutung der 4. Universellen Definition des Myokardinfarkts
Dennis Eckner, Matthias Pauschinger, Fadil Ademaj, Kristinko Martinovic
Optimal antiplatelet and anticoagulation strategies in acute coronary syndromes
Dominik Rath, Tobias Geisler
Multivessel vs. culprit-lesion only percutaneous coronary intervention in ST-elevation myocardial infarction
Hans-Josef Feistritzer, Alexander Jobs, Steffen Desch, Holger Thiele
Radial access first for PCI in acute coronary syndrome
Jeffrey A. Marbach, Saad Alhassani, George Wells, Michel Le May
Anticoagulant plus antiplatelet therapy for atrial fibrillation
K. Bode, G. Hindricks, J. M. ten Berg, P. Whittaker
Individual programming of current multiprogrammable pacemakers
T. Tischer, A. Bebersdorf, C. Albrecht, J. Manhart, E. Caglayan, A. Öner, H. Ince, J. Ortak, A. Büttner, E. Safak
Long-term vitamin-K antagonist use and coronary artery calcification
S. Ünlü, A. Şahinarslan, H. K. Kılıç, G. Gökalp, B. Sezenöz, G. Erbaş, R. M. Yalçın, M. Araç
Clinical outcomes after tricuspid surgery
J. Rodríguez-Capitán, V. M. Becerra-Muñoz, B. Pérez-Villardón, G. Sánchez-Espín, M. Such-Martínez, A. Flores-Marín, I. Fernández-Pérez, A. García-Bellón, C. Porras-Martín, M. J. Mataró-López, J. M. Melero-Tejedor, E. Rodríguez-Caulo, J. J. Otero-Forero, A. Cordero-Aguilar, R. López-Salguero, J. J. Gómez-Doblas, E. de Teresa-Galván
Efficacy and safety of rosuvastatin vs. atorvastatin in lowering LDL cholesterol
L. Zhang, S. Zhang, Y. Yu, H. Jiang, J. Ge
Therapeutisches Management des nichtvalvulären Vorhofflimmerns
M. A. Gunawardene, J. Hartmann, M. Jularic, C. Eickholt, N. Gessler, S. Willems